BlackRock Advisors’s Allergan plc AGN Stock Holding History

BlackRock Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$234M	Sell	1,113,124 -31,785	-3%	-$6.58M	0.24%	101
2016 Q3	$264M	Sell	1,144,909 -212,316	-16%	-$51.9M	0.27%	94
2016 Q2	$314M	Sell	1,357,225 -227,000	-14%	-$52.3M	0.32%	80
2016 Q1	$425M	Sell	1,584,225 -35,473	-2%	-$10.2M	0.45%	51
2015 Q4	$506M	Sell	1,619,698 -233,702	-13%	-$69.6M	0.54%	40
2015 Q3	$504M	Buy	1,853,400 +18,346	+1%	+$5.64M	0.54%	36
2015 Q2	$557M	Sell	1,835,054 -246,017	-12%	-$73.4M	0.58%	36
2015 Q1	$619M	Buy	2,081,071 +456,019	+28%	+$130M	0.63%	28
2014 Q4	$418M	Buy	1,625,052 +458,771	+39%	+$115M	0.42%	58
2014 Q3	$281M	Buy	1,166,281 +869,091	+292%	+$194M	0.28%	89
2014 Q2	$66.3M	Sell	297,190 -58,648	-16%	-$12.1M	0.06%	287
2014 Q1	$73.2M	Buy	355,838 +57,777	+19%	+$11.4M	0.07%	277
2013 Q4	$50.1M	Buy	298,061 +9,512	+3%	+$1.49M	0.05%	345
2013 Q3	$41.6M	Buy	288,549 +57,299	+25%	+$7.63M	0.04%	362
2013 Q2	$29.2M	Buy	+231,250	New	+$26.2M	0.03%	427

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock Advisors's AGN Position: Q4 2016 in Review

BlackRock Advisors reduced its Allergan plc (AGN) stake by 2.8% in Q4 2016, selling an estimated $6.58M and leaving 1,113,124 shares worth $234M. The position accounts for 0.24% of the portfolio, ranked #101.

BlackRock Advisors first reported a position in AGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $619M in Q1 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

BlackRock Advisors held 1,113,124 shares of Allergan plc worth $234M as of Q4 2016.
BlackRock Advisors sold 31,785 Allergan plc shares in Q4 2016, an estimated $6.58M.
Allergan plc made up 0.24% of BlackRock Advisors's portfolio in Q4 2016, its #101 holding.
BlackRock Advisors first reported a position in Allergan plc in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Allergan plc position peaked at $619M in Q1 2015.
1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.